Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among Men.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 31479145.
- Also identified by DOI 10.1001/jamainternmed.2019.2813 and PMC identifier 6724526.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study assesses the association between initiation of sodium-glucose cotransporter 2 (SGLT-2) inhibitor treatment and the risk of hospitalization for Fournier gangrene among men.